# Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir

> **NCT04962230** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 12 (actual)

## Conditions studied

- Healthy Participant

## Interventions

- **DRUG:** PF-07321332/ritonavir
- **DRUG:** Carbamazepine
- **DRUG:** PF 07321332/ritonavir

## Key facts

- **NCT ID:** NCT04962230
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-15
- **Primary completion:** 2021-10-09
- **Final completion:** 2021-10-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2023-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04962230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04962230, "Drug-Drug Interaction Study Assessing Effect of Carbamazepine on PF-07321332 Boosted With Ritonavir". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04962230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*